Positive EBITDA Arrives Exactly as Promised — But Orders Crater 25%, Customers Breach 600K, and 2026 Guidance of $140-150M Means Another Year of Double-Digit Shrinkage

Results vs. Consensus

Quality of Beat/Miss

• Revenue ($42.4M, -14.3% YoY): The YoY decline rate worsened from Q3's -9.4% to -14.3%, reversing three quarters of improving trajectory. The sequential decline of -2.9% also missed the "roughly flat" guidance. Both misses are directly attributable to the 65% advertising cut: with virtually no customer acquisition spend, new orders dried up and lapsed subscribers weren't replaced. Revenue quality improved (higher rev/order, lower returns implied by better inventory management), but revenue quantity deteriorated sharply.
• EPS (-$0.05 vs -$0.09): The $0.04 beat continues the pattern of cost-driven outperformance. Total operating expenses declined 30% YoY, with every line item showing double-digit reductions. The question isn't whether management can cut costs — they've proven that emphatically — it's whether the cost structure is sustainable at the lower revenue base, or whether further cuts become necessary.
• EBITDA (+$1.6M): The signature achievement of Q4. But the composition matters: $1.9M in restructuring add-backs make the difference between positive and negative EBITDA. On a GAAP operating basis, the loss was still $1.6M. The positive EBITDA should be viewed as proof-of-concept — the business can generate positive adjusted EBITDA at ~$42M/quarter revenue with a lean cost base — rather than as a sustainable run rate. The 2026 guidance of "approximately breakeven" suggests management agrees.

Key KPIs — Full Year 2025 Progression

Key Topics & Management Commentary

Overall Management Tone: Reflective and humbled but not defeated. Yurcisin's acknowledgment that "the impacts lasted longer than planned" and "we saw more churn than we originally expected" is the most candid assessment of 2025 yet. The forward framing around "rebuilding" and "responsible scaling" is realistic — a marked contrast from Q2's ambitious Q4-growth pledges. The tone matches the reality: the company survived 2025, but at a significant cost.

1. The Restructuring-Powered EBITDA Milestone

Q4 adjusted EBITDA of +$1.6M was achieved through a combination of three levers: (1) advertising slashed 65% from $3.0M to $1.0M, saving $2.0M; (2) the November RIF delivering roughly $1.3M in Q4 savings (annualized $5M ÷ 4); and (3) product development cut 59% YoY. The restructuring charges of $1.9M (severance/RIF costs) were added back to arrive at the positive figure.

"We finished 2025 in line with our revised revenue and Adjusted EBITDA guidance and returned to positive Adjusted EBITDA in the fourth quarter." — Jeff Yurcisin, CEO

On a full-year basis, adjusted EBITDA was -$2.2M versus the guided range of "negative low single-digit millions to breakeven" — meeting the low end. FY net loss narrowed 57% to $11.7M from $27.4M.

Assessment: Management delivered exactly what they promised. In a year full of broken commitments (platform timeline, Q4 growth target), the EBITDA delivery stands out as the one promise kept. The question is whether Q4's cost structure is the new normal or a temporarily suppressed level. With advertising at $1M (6x below the $6M+ run rate needed to grow), the positive EBITDA is mechanically achievable but strategically unsustainable. The 2026 "breakeven" guide implies advertising will be increased modestly, which will compress EBITDA back toward zero. This was a milestone, not a steady state.

2. Orders Collapse: The Price of Cost Discipline

DTC orders of 539K represented a 25% YoY decline and a 12.9% sequential collapse — by far the worst quarterly order number of 2025. The order trajectory through the year tells the story of the advertising-growth trade-off: Q1 622K → Q2 640K (+3.4% on maintained ad spend) → Q3 619K (-3.3% as efficiency weakened) → Q4 539K (-12.9% as ad spend was slashed). The Q4 collapse demonstrates that Grove's order volume is still heavily dependent on paid acquisition.

Annualized, 539K quarterly orders implies ~2.2M orders/year. At $69.50/order, that's ~$150M in DTC revenue. Add QVC/wholesale ($2.9M/quarter × 4 = $11.6M) and the total is ~$162M — above the 2026 guidance range of $140-150M, suggesting management expects Q1-Q2 to be significantly weaker before H2 recovery.

Assessment: The order collapse confirms the bear thesis that Grove cannot generate organic demand growth without paid acquisition. The 25% YoY decline is the worst in the company's history as a public company. Management's response — "we do not view the customers who churned as gone forever" — is optimistic but unproven. The mobile app, loyalty program, and subscription enhancements are designed to improve retention and organic reactivation, but none have been measured at scale yet.

3. Revenue Per Order: The Silver Lining That Matters

DTC revenue per order reached $69.50, up 4.1% YoY and 4.9% sequentially. This is the highest level since at least early 2024 and represents four consecutive quarters of improvement after the Q2 trough of $65.22. The trend suggests that customer attrition is disproportionately removing low-value, low-frequency customers, leaving a more concentrated base of loyal, higher-spending subscribers.

At $69.50/order with 79% of orders coming from subscriptions, the average subscriber is placing ~4 orders/year for annual revenue of ~$278 — up from ~$244 estimated at Q1. This per-customer economics improvement is the foundation for any rebuild.

Assessment: Revenue per order is the most important positive trend in the report. If the customer base stabilizes at 550-600K with $70+/order, the annual revenue run rate would be $154-168M — within the guided range and potentially sustainable with breakeven EBITDA. The risk is that even the loyal core begins to attrite as the product experience remains suboptimal. But the direction is right, and it suggests a smaller but healthier business is emerging from the 2025 wreckage.

4. The 2026 Framework: "Rebuilding" From a Lower Base

FY2026 guidance of $140-150M revenue with approximately breakeven EBITDA represents a 14-19% decline from 2025's $174M. Q1 is the trough (seasonality + continued ad suppression at ~$1M), with sequential improvement through the year driven by: (1) the new mobile app (launched February 2026), (2) subscription management improvements (expected by Q2), (3) Grove Green Rewards loyalty program, and (4) gradual advertising ramp "only when cohorts meet clear hurdles."

"2026 is for us: a year of rebuilding that momentum...we expect to deliver sequential revenue growth through the year while maintaining profitability discipline." — Jeff Yurcisin, CEO

The midpoint of $145M implies roughly: Q1 ~$34M, Q2 ~$35M, Q3 ~$37M, Q4 ~$39M. This represents a significantly smaller business than 2025's $174M, but the sequential improvement narrative is credible if the mobile app and loyalty program drive retention improvement.

Assessment: This is the third consecutive year of double-digit revenue decline (2023: ~-20%, 2024: -15%, 2025: -15%, 2026E: -14% to -19%). The shrinkage has been remarkably persistent. The bull case for 2026 requires at least one of the new customer engagement tools to work — the mobile app, the loyalty program, or the subscription enhancements — and for advertising to resume at efficient economics. The breakeven EBITDA guide means management isn't expecting profitability either; they're aiming for "not losing money while we try to fix the growth engine." This is a reasonable strategy if the customer base stabilizes; it's a path to irrelevance if it doesn't.

5. Strategic Alternatives: Eulogy for a Catalyst

The strategic alternatives commentary has been reduced to a single boilerplate sentence: "We continue to evaluate strategic options to maximize shareholder value. These may include additional acquisitions or partnerships, divestitures, and other strategic options." No mention of HumanCo, no working group update, zero transaction costs in the second half of 2025.

Eight months after the HumanCo letter sparked a 55% rally, the stock has round-tripped to $1.28 — barely above the $1.19 pre-letter price. The market has effectively written off the strategic alternatives premium.

Assessment: We are formally removing the strategic transaction as a near-term catalyst. The probability has declined from our Q2 estimate of 25-30% to ~10% or less for the next 12 months. The assets that HumanCo cited — 700K customers, strong subscription metrics, $500M NOLs — have deteriorated (now 599K customers, declining engagement, same NOLs). Without a material change in the competitive landscape or a new activist push, a strategic transaction is unlikely at current terms. The company's primary path to value creation is now the standalone operating turnaround.

Guidance & Outlook

Implied 2026 quarterly cadence: If FY is $145M (midpoint) with Q1 as trough: Q1 ~$34M → Q2 ~$35M → Q3 ~$37M → Q4 ~$39M. Management declined to specify the advertising ramp: "We are not going to give specifics as to what we think that ramp is going to look like over the course of the year." This means the growth trajectory is entirely contingent on decisions that haven't been made yet — a level of uncertainty that makes forward modeling difficult.

Breakeven EBITDA at $140-150M revenue implies an operating expense run rate of ~$75-80M (vs. $105M in FY2025), requiring an additional ~$25M in cost reductions beyond the $5M RIF. Some of this comes from the organic ad reduction (FY2025 ad was $9.7M; at $1M/quarter for FY2026, that's $4M, saving $5.7M). The remaining ~$15-20M in savings would need to come from continued SG&A and product development optimization. The math works, but it's tight.

Analyst Q&A Highlights

Growth Reacceleration Path

• Susan Anderson, Canaccord Genuity: Asked about sequential growth drivers and when advertising ramps. Yurcisin pointed to the mobile app as "a really big change" and noted "early positive signals." Siragusa declined to provide specifics on the ad ramp.
  Assessment: The mobile app launched in February 2026 and hasn't been measured yet. The refusal to guide on ad spend means the Street cannot model the growth trajectory. This ambiguity will keep the stock in a holding pattern until Q1 2026 results provide evidence.

Category Expansion

• Anderson: Asked about white space. Yurcisin described drop-ship capabilities for higher-AOV categories like air filters and mattresses: "everything going into air filters and even potentially mattresses."
  Assessment: Drop-ship adds SKUs without inventory risk, which is smart. But air filters and mattresses are highly competitive, low-margin categories dominated by Amazon. The strategic logic (higher AOV lifts revenue/order) is sound, but execution risk is high for a company still fixing its core platform.

Margin Cadence

• Anderson: Siragusa indicated gross margin will be "flat" and opex benefits from "the RIF in the fourth quarter reset our cost base lower."
  Assessment: Stable 53% gross margins at a lower revenue base means gross profit declines proportionally with revenue. The cost base reset is the sole lever for EBITDA improvement. This constrains upside unless revenue stabilizes.

What They're NOT Saying

1. No advertising ramp schedule: Management explicitly refused to provide specifics on when and by how much advertising will increase in 2026. This is the single most important variable for revenue trajectory, and its absence from guidance makes the outlook nearly unmodelable. The omission suggests management hasn't committed to a plan, which means they're still watching Q1 data.
2. No customer count target for 2026: With active customers at 599K and declining 9% per quarter, the absence of any target or stabilization timeline for the customer base is conspicuous. Management said "we do not view the customers who churned as gone forever" but provided no evidence or timeline for reactivation.
3. No update on NYSE remediation: Market cap at ~$51M provides minimal buffer above $50M. Stockholders' deficit is -$17M. No mention of compliance timeline, remediation plan acceptance, or cure period progress. This issue has been absent from every earnings communication since Q1.
4. No discussion of preferred stock conversion or capital structure: The $24.8M preferred stock continues to sit above common equity, consuming value. No mention of potential conversion, redemption, or restructuring. At current market cap (~$51M), the preferred represents 49% of enterprise value equivalent — a massive overhang.
5. No quantification of QVC/wholesale revenue mix: The $2.9M QVC reference was the first disclosure of non-DTC revenue. The lack of formal reporting of this channel's contribution makes it difficult to decompose the DTC vs. wholesale growth trajectories.

Market Reaction

• Pre-earnings close (Mar 5): $1.28
• Post-earnings open (Mar 6): $1.27 (-0.8%)
• Mar 6 close: $1.29 (+0.8% from pre-earnings)
• Volume: 331,277 (15.6x normal)
• Mar 10: $1.28 (flat)
• Market cap at $1.28: ~$50.9M
• Analyst: Canaccord Genuity (Strong Buy, $2.00 PT, last updated Nov 2025)

The essentially flat reaction (+0.8%) despite the volume spike (15.6x) reflects a market that had already priced in the mixed outcome. The stock declined steadily from $1.47 (post-Q3) to $1.28 in the four months leading up to earnings, absorbing the negative expectations. The EPS beat and positive EBITDA prevented further selling, while the revenue miss, order collapse, and weak 2026 guidance prevented a rally. At $1.28, the market cap is $50.9M — barely above the $50M NYSE threshold — effectively pricing the stock at the minimum listing requirement.

Street Perspective

Debate: Is This a Stabilizing Business or a Melting Ice Cube?

Bull view: Grove proved it can generate positive EBITDA and breakeven cash flow. The cost base has been right-sized. Revenue per order at $69.50 and climbing shows the core customer is healthy. The mobile app, loyalty program, and subscription improvements are all live or launching in H1 2026. At $1.28 and 0.30x EV/revenue, the stock prices in permanent decline; any evidence of stabilization re-rates it to 0.40-0.50x ($1.80-2.25). Canaccord's $2.00 target implies 56% upside.

Bear view: This is a business that lost 208,000 customers in 2025 (807K Q1 2024 → 599K Q4 2025) and is guiding for another year of double-digit revenue decline. Orders fell 25% in Q4. The "positive EBITDA" required a restructuring add-back. The platform migration — now a year old — has been catastrophic, and the replacement app has been live for less than a month. The 2026 guidance of $140-150M with breakeven EBITDA means no earnings growth and no revenue growth. Who buys this stock?

Our take: Both arguments have merit, and neither is decisively stronger. The company has demonstrated it can survive at the current scale — that was the open question in Q1 2025, and it's now answered. But survival isn't a thesis; growth is. The next 2-3 quarters will determine whether the mobile app and loyalty program can bend the customer attrition curve. Until then, the stock is fairly priced at $1.28 for the information available. The downside is limited by the cost discipline (cash is stable, EBITDA near breakeven), and the upside is limited by the absence of growth evidence.

Debate: Does the $2.00 Canaccord Target Still Make Sense?

Bull view: Canaccord's $2.00 implies ~$80M market cap on 40M shares, or approximately 0.55x 2026E revenue of $145M. This is within the range for a subscription DTC brand with 53% gross margins, a loyal customer base, and $500M in NOLs. The target requires nothing heroic: moderate customer stabilization and continued cost discipline.

Bear view: The $2.00 target was set when customers were 660K+ and the Q4 growth narrative was still alive. At 599K customers and declining, with 2026 revenue guidance of $140-150M (below Canaccord's prior estimates), the target needs revision. Comparable DTC brands in secular decline trade at 0.2-0.3x revenue, not 0.5x+.

Our take: The $2.00 target is aspirational and likely to be revised lower when Canaccord updates post-Q4. A more realistic base case valuation is 0.35-0.45x 2026E revenue = $1.30-1.70. The stock at $1.28 sits at the bottom of this range, which is why we maintain Hold rather than downgrade.

Model Implications

Valuation: At $1.28, market cap of ~$51M, and EV of approximately $47M ($51M + $7.5M debt + $0.9M derivatives - $11.8M cash), Grove trades at 0.27x trailing revenue and 0.32x 2026E revenue (midpoint $145M). This is distressed-territory pricing but arguably appropriate for a business with 4 years of consecutive revenue decline, negative equity, and no clear path to growth. The bull case to $1.80-2.00 requires customer stabilization + continued cost discipline. The bear case to $1.00-1.10 materializes if Q1 2026 revenue comes in below $33M or customer attrition accelerates further.

Thesis Scorecard Post-Earnings

Overall: The 2025 story ends with a company that proved it can survive but not yet that it can grow. The four-quarter arc tells it clearly: Q1 (existential crisis, Underperform initiation) → Q2 (positive OCF + HumanCo catalyst, upgrade to Hold) → Q3 (growth target abandoned, profitability pivot) → Q4 (profitability delivered, but at the cost of accelerating customer loss). The stock's round-trip from $1.36 to $1.84 to $1.28 mirrors the narrative: hope followed by reality.

Action: Maintain Hold. The stock at $1.28 is approximately fairly valued for the visible trajectory. For new money: this is not a buy until Q1 2026 data shows the mobile app and loyalty program are bending the customer attrition curve. Specifically, we need to see: (1) sequential customer count decline of <5% Q/Q (versus -9.2% in Q4), (2) evidence that revenue per order holds above $68, and (3) confirmation that EBITDA stays near breakeven as advertising resumes. For existing holders: the position is worth maintaining through Q1 2026 results — if the customer metrics stabilize, the stock re-rates to $1.50-1.80; if they don't, it's time to cut.